Category: Multiple Sclerosis

Siponimod, sold under the brand name Mayzent, is a selective sphingosine-1-phosphate receptor modulator for oral use that is used for multiple sclerosis (MS).[7] It is intended for once-daily oral administration.[8][7] In March 2019, it was approved in the United States to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.&a... [wikipedia]

Related Brands

Drugs with the same active ingredients